| Literature DB >> 16769962 |
M J Strong1, W Yang, W L Strong, C Leystra-Lantz, H Jaffe, H C Pant.
Abstract
The authors have characterized frontal cortical tau protein in cognitively intact (4) and cognitively impaired (ALSci, 4) ALS patients and compared it with control (2) or Alzheimer disease (AD, 1)- derived tau. The authors observed expression of both 3R and 4R tau isoforms; increased insoluble tau protein; phosphatase resistance; and hyperphosphorylation at T175, S208, and S210. Soluble tau from both AD and ALSci was also phosphorylated at S237. Tau hyperphosphorylation is associated with ALS.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16769962 DOI: 10.1212/01.wnl.0000218161.15834.db
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910